Pliant Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.

Top 25 shareholders own 94.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.55%	Deep Track Capital, LP	5,750,000	US$72.5m	4.55%	2.54%
7.97%	BlackRock, Inc.	4,801,517	US$60.6m	11.1%	no data
6.54%	FMR LLC	3,939,405	US$49.7m	-4.29%	no data
6.28%	T. Rowe Price Group, Inc.	3,785,916	US$47.8m	13%	no data
6.03%	First Light Asset Management, LLC	3,634,510	US$45.9m	23.9%	4.31%
5.95%	Laurion Capital Management LP	3,583,567	US$45.2m	12.5%	1.66%
5.09%	The Vanguard Group, Inc.	3,065,869	US$38.7m	4.09%	no data
4.99%	CHI Advisors LLC	3,004,199	US$37.9m	-0.33%	14.43%
4.48%	Redmile Group, LLC	2,696,648	US$34.0m	0.69%	1.42%
4.1%	Third Rock Ventures, LLC	2,472,027	US$31.2m	0%	12.12%
3.57%	Novartis AG	2,153,526	US$27.2m	0%	no data
3.35%	Polar Capital Holdings Plc	2,015,000	US$25.4m	21%	0.11%
3.03%	Great Point Partners, LLC	1,823,184	US$23.0m	3.87%	3.33%
2.62%	Citadel Advisors LLC	1,578,514	US$19.9m	3.84%	0.02%
2.62%	Casdin Capital, LLC	1,577,108	US$19.9m	0%	1.77%
2.59%	Franklin Resources, Inc.	1,562,858	US$19.7m	3.85%	0.01%
2.22%	State Street Global Advisors, Inc.	1,335,278	US$16.8m	1.33%	no data
2.19%	Pictet Asset Management Limited	1,318,804	US$16.6m	46.3%	0.01%
2.13%	RA Capital Management, L.P.	1,281,000	US$16.2m	-27.3%	0.22%
1.97%	Geode Capital Management, LLC	1,187,198	US$15.0m	5.41%	no data
1.91%	Granahan Investment Management, LLC	1,150,766	US$14.5m	22.5%	0.52%
1.64%	Deutsche Asset & Wealth Management	984,992	US$12.4m	-0.06%	0.01%
1.59%	Dws Investment Gmbh	955,133	US$12.1m	0%	0.01%
1.51%	Capital Research and Management Company	912,467	US$11.5m	0%	no data
1.04%	Bernard Coulie	628,166	US$7.9m	3.81%	no data